Sequence analysis of cell-free DNA derived from cultured human bone osteosarcoma (143B) cells.
Tumour Biol
2018
40
9
Association between circulating biomarkers of fibrosis and left atrial
voltage in patients undergoing atrial fibrillation ablation. A pilot
study
Eur Heart J
2018
39
201-201
Repeated mutKRAS ctDNA measurements in patients with advanced pancreatic
cancer patients: Kinetics, response prediction and therapy monitoring in
comparison to protein-based tumor markers
Ann Oncol
2018
29
Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer.
Ann Oncol
2018
29
12
2348-2355
Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA.
Oncotarget
2018
9
32
22523-22536
Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer.
Tumour Biol
2018
40
4
The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature
Biol Rev Camb Philos Soc
2018
93
3
1649-1683
Potential of circulating nucleosome-associated histone modifications in cancer
Transl Cancer Res
2018
7 2
S185-S191
Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Am J Cardiol
2018
121
4
461-468
Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.
Biomarkers
2018
23
3
299-304